Ion channel (plasma membrane type)

Plasma membrane ion channels are **pore-forming transmembrane proteins** that selectively allow ions such as sodium, potassium, calcium, chloride, or protons to cross the cell's plasma membrane down their electrochemical gradients. They play essential roles in establishing resting membrane potential, generating action potentials in excitable cells like neurons and muscle fibers, mediating synaptic transmission via ligand-gated types at synapses, regulating secretion processes including hormone release and neurotransmitter exocytosis, controlling cell volume by osmoregulation mechanisms, and participating in diverse signaling pathways across nearly all tissues.[1][2][3] Ion channels can be classified by their gating mechanism—voltage-gated open/close based on changes in electrical potential across the plasma membrane; ligand-gated respond to chemical messengers such as neurotransmitters; mechanosensitive respond to physical deformation—and by their selectivity for particular ions.[5] Dysfunction or mutation leads directly to a group of diseases known as **channelopathies**, which include epilepsy (neuronal sodium/potassium), cystic fibrosis (chloride), long QT syndrome/cardiac arrhythmias (potassium/sodium/calcium), among others.[3] Because they underlie rapid electrical signaling required for nervous system function and heart rhythm—and because many drugs act directly upon them—plasma membrane ion channels represent one of the most important classes of therapeutic targets. However "plasma membrane ion channel" is not a single molecular entity but rather an umbrella term covering hundreds of distinct proteins with unique structures/functions/localizations/drug sensitivities.[7]

Other names

Plasma membrane ion channelMembrane ion channelCell surface ion channel

Mechanisms depend on the drug and specific ion channel subtype but generally include: - Blockade or inhibition of ion flow through the pore - Modulation of gating properties to increase or decrease open probability - Allosteric modulation via ligand binding for ligand-gated types